Search Results

Baxter and bioMérieux Announce Collaboration to Improve Identification and Treatment of Acute Kidney Injury

Baxter International Inc. (NYSE: BAX), a global leader in acute care, and bioMérieux, a world leader in the field of in vitro diagnostics, announced an agreement to develop future biomarkers with the goal to rapidly identify and inform treatment of acute kidney injury (AKI). The announcement was made at the International Symposium on Intensive Care and Emergency Medicine (ISICEM) this week.

Standing Proudly Behind Our Products

Our employees are dedicated to patient safety.

Baxter to Host First Quarter 2019 Financial Results Conference Call for Investors

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its first quarter 2019 financial results on Thursday, April 25, 2019, at 7:30 a.m. Central Time. To access the call, dial (844) 886-1929 (domestic) or (225) 239-4663 (international).  Please dial into the call at least 10 minutes prior to the start for the operator to connect you. The Conference ID is 6993043.

Baxter Announces U.S. FDA Approval and Launch of Ready-To-Use Cardiovascular Medicine Eptifibatide

Baxter International Inc. (NYSE:BAX), a global leader in sterile medication production and delivery, today announced the U.S. Food and Drug Administration (FDA) approval and launch of ready-to-use eptifibatide. Baxter’s presentation of eptifibatide is the first of its kind available in a flexible container.

Baxter Honored as a 2019 'Top Company for Executive Women' By the National Association for Female Executives

Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced today that it has been named one of the 2019 NAFE Top Companies for Executive Women by the National Association for Female Executives (NAFE). This recognition highlights the company’s efforts to advance women in leadership and foster an inclusive and diverse culture.  

"I Helped Make That"

Mentoring the next generation of innovators is important to our employees.

Motivated by Curiosity

Through inquisitive minds and innovative strategy, we are providing better healthcare solutions.

Baxter Declares Quarterly Dividend

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that its Board of Directors has declared a quarterly cash dividend of $0.19 per share of common stock. The dividend is payable on April 1, 2019, to shareholders of record as of March 1, 2019. The indicated annual dividend rate is $0.76 per share of common stock.

Advancing Scientific Research to Improve Outcomes in the ICU

Investigator initiated research helps advance new innovations in critical care

Baxter to Present at the Barclays Global Healthcare Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Barclays Global Healthcare Conference in Miami, Fla. on March 12, 2019.  Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 3:20 p.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through September 6, 2019.